Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms).
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Clinical and epidemiological profiles of non-traumatic myelopathies.
Clinical perspectives of TRAIL: insights into central nervous system disorders.
[Protocol for neurophysiological studies of the pelvic floor to appraise anorectal dysfunction in patients with multiple sclerosis].
Cellulose/soy protein composite-based nerve guidance conduits with designed microstructure for peripheral nerve regeneration.
Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8-B4 microglia.
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Positive association of vitamin d receptor gene variations with multiple sclerosis in South East Iranian population.
Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Deficiency of NF-kappaB c-Rel Accelerates the Development of Autoimmune Diabetes in Non-Obese Diabetic Mice.
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.
Inhibin-a immunoreactivity in nervous system lesions.
Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
Studying the Effects of Semaphorins on Oligodendrocyte Lineage Cells.
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.
Acute Respiratory Failure due to Neuromyelitis Optica Treated Successfully with Plasmapheresis.
Transdermal immunotherapy: Past, present and future.
Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors.
Online CBT in patients with multiple sclerosis and depression.
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis.
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
Diffusion Weighted MRI Characterization of White Matter Injury Produced by Axon-sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.
Pages
« first
‹ previous
…
717
718
719
720
721
722
723
724
725
…
next ›
last »